HCPCS Level II
J0896
Injection, luspatercept-aamt, 0.25 mg
Codes near J0896
These sit next to J0896 in the CMS Level II file. All J codes
- J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
- J0894Injection, decitabine, 1 mg
- J0895Injection, deferoxamine mesylate, 500 mg
- J0897Injection, denosumab, 1 mg
- J0898Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0899Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0900Injection, testosterone enanthate and estradiol valerate, up to 1 cc
- J0901Vadadustat, oral, 1 mg (for esrd on dialysis)
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 59572-0711-01 | Reblozyl | Celgene Corporation | 100 |
| 59572-0775-01 | Reblozyl | Celgene Corporation | 300 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.
Run it in Rivvi
Check every code on your export
Upload a claims or problem-list export. Rivvi flags codes that are not billable, replaced, or unspecified when a specific code exists.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.